Patient Guide: A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 9 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06877533
Status: TERMINATED
Condition: Selected Advanced Solid Tumors
Phase: PHASE1

Find a Study Location Near You

This study is available at 9 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Denver, Colorado
  • Sarasota, Florida
  • Boston, Massachusetts
  • • And 6 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily